UBS Slides As Net Profit Halved, Despite Wealthy Client Inflow
UBS’s Swiss-listed shares slid in early Tuesday trading after the bank posted a 52% year-on-year decrease in net profit in the first quarter. Despite the slump, the bank recorded strong customer inflows while preparing to acquire rival Credit Suisse. This marks the first financial results since UBS announced the takeover of Credit Suisse last month.
UBS disclosed its weakest quarterly earnings in more than three years and a dim outlook for interest income in its wealth management division. It said net profit came in at $1.03 billion for the first quarter, missing analyst expectations of around $1.75 billion for the period.
Switzerland’s largest bank experienced a $665 million hit in net income due to US residential mortgage-backed securities litigation. It also said it’s in talks with the US Department of Justice to settle a 2018 civil complaint.
That news overshadowed the inflow of $28 billion from high-net-worth clients during the quarter, $7 billion arriving in the ten days following the announcement of the Credit Suisse takeover in March.
Here are other highlights of the first quarter:
- Revenues reached $8.75bln vs. 9.38bln a year ago
- Operating expenses were $7.2bln from $6.6bln a year ago
- CET 1 capital ratio, a measure of bank solvency, came in at 13.9% vs. 14.1% a year ago
Retaining clients and assets is a major challenge for Sergio Ermotti, who returned as UBS CEO to oversee the historic merger. The results didn’t include Credit Suisse’s operations since the merger has yet to be finalized.
Credit Suisse revealed on Monday that it borrowed far more from the Federal Reserve’s liquidity backstop program than previously known, with clients continuing to withdraw after the deal was announced.
In an interview with Bloomberg TV, Ermotti said the inflows at UBS are “a sign of confidence of our clients.” He noted that the inflows weren’t just from Credit Suisse clients but also from the US.
During the banking crisis last month, UBS froze its buyback program. Ermotti said during the interview:
“We are reiterating our intention to have a progressive cash dividend increase every year and we definitely have an intention to resume share buybacks when its appropriate.”
UBS shares fell as much as 5% Tuesday morning.
Here is what analysts are saying (courtesy of Bloomberg):
JPMorgan (Kian Abouhossein, overweight) says while earnings can be seen as weak, long-term view unchanged
- Says consensus EPS could be cut 3%-5% after bank gave worse than expected NII guidance for wealth management
- Notes more details on Credit Suisse merger were expected
KBW (Thomas Hallett, underperform) says results were a “lackluster set,” with wealth management underwhelming and also sees material downgrades to 2023 expectations following NII guidance
- Sees consensus going down 5% as bank guided that wealth management, personal and corporate net interest income to be broadly in-line with 2022 4Q annualized
- Capital below consensus
- Says results disappoint, remains underperform
Citi (Andrew Coombs, buy) sees earnings as uneventful, notes there could be disappointment on litigation charge, cautious outlook commentary
RBC (Anke Reingen, sector perform) notes 1Q missed estimates on higher litigation provisions and also sees consensus estimates earnings cuts on the NII guidance
Moving forward, UBS must integrate Credit Suisse, and any overlapping business units will likely result in thousands of job cuts.
Tyler Durden Tue, 04/25/2023 – 07:45
Source: https://freedombunker.com/2023/04/25/ubs-slides-as-net-profit-halved-despite-wealthy-client-inflow/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
